07 . 13
MicroMass Communications, Inc. was named to the top 100 healthcare agencies for the 11th year in a row. Learn more.
Read our Expert on Call article on patient-provider dialogue. We focus on how pharma can help providers optimize conversations with patients.
MicroMass was a sponsor at the 3rd annual MM&M Transforming Healthcare Conference.
05 . 08
The annual Med Ad News agency profile provides insight into the MicroMass Communications’ specialized structure, services offered, accomplishments, and future plans.
04 . 25
In our article featured in BioPharmaDive, Rob Peters discusses how outcomes can be improved prior to drug launch. Take a look.
MicroMass was featured in the MM&M ebook that looks at how pharma marketers can leverage behavioral techniques for patients and providers.
Nicotrax, a partner of MicroMass Communications, recently concluded its 4-week smoking cessation study.
03 . 21
In our first of 3 patient-provider Expert on Call articles for PM360, we analyze the importance of patient-provider dialogue on the pharma brand.
MicroMass was prominently featured in the MM&M article on selling behavioral science to clients. Take a look.
MicroMass contributed to the PharmaVOICE article, C-Suite Outlook: Leading Through Extraordinary Change. Take a look at their questions, and more importantly, our answers.
01 . 19
PM360 has named MicroMass Communications, Inc. as the Self-promotion Pharma Choice Silver winner.
MicroMass was selected for the PM360 Innovation issue. Read more about how MicroMass is striving to meet both the clinical and psychosocial needs of patients.
12 . 14
Read our editorial contribution in this month’s PharmaVOICE magazine. Alyson Connor, president of MicroMass discusses the impact of Triple Aim, which is an initiative designed to improve patient care, patient health, and reduce healthcare costs.
12 . 13
MicroMass Communications, Inc. is hiring. Learn more about our open positions and apply today!
11 . 18
MicroMass was selected to present a poster revealing the results of its clinical study based on its behavioral intervention application, Time 2 Focus, for adults with type 2 diabetes.
The MicroMass unbranded campaign for Atopic Dermatitis Insider was recognized as an Award of Excellence winner in the 30th annual Rx Club Awards. Atopic Dermatitis Insider received the honor for Best Integrated Campaign.
MicroMass was a panelist at the 2016 UNC Kenan-Flagler Healthcare Conference at the University of North Carolina at Chapel Hill.
SaxendaCare®, winner of the Trailblazer Award in the Persistence/Adherence Program category, was featured in the October issue of PM360.
MicroMass’ client Jenn Thomas was featured in the October issue of PM360 after being honored as the PM360 Trailblazer Marketer of the Year.
In PharmaVOICE, we discuss how pharma should change its traditional model to address the whole patient needs—both clinical and psychosocial needs.
09 . 23
MicroMass was honored with a prestigious PM360 Trailblazer Award for SaxendaCare®. SaxendaCare® was the winner in the Persistence/Adherence program category.
MicroMass client, Jennifer Thomas, won Marketer of the Year at the prestigious PM360 Trailblazer Awards held in New York City.
MicroMass Communications, Inc., a Cary-based healthcare communications agency, and Strategic Pharma Solutions, Inc. (SPS), a Raleigh-based healthcare communications agency, announced today that the two companies have merged.